Results 101 to 110 of about 33,477 (277)

Canagliflozin alleviates progestin resistance by suppressing RARβ/CRABP2 signaling in THRB knockout endometrial cancer cells

open access: yesFrontiers in Pharmacology
IntroductionProgestin resistance has emerged as a significant barrier to the conservative management of endometrial cancer (EC). The mechanisms underlying progestin resistance in endocrine therapy remain incompletely understood.
Ye Yang   +13 more
doaj   +1 more source

Estrogen Plus Progestin Hormone Therapy and Ovarian Cancer

open access: yes, 2020
Background: Menopausal estrogen-alone therapy is a risk factor for endometrial and ovarian cancers. When a progestin is included with the estrogen daily (continuous estrogen-progestin combined therapy), there is no increased risk of endometrial cancer ...
Webb, Penelope M.   +57 more
core   +1 more source

HUBUNGAN KECEMASAN DENGAN KETEPATAN KUNJUNGAN ULANG AKSEPTOR KB SUNTIK PROGESTIN PADA MASA PENDEMI COVID-19 DI KLINIK PRATAMA PMI DIY [PDF]

open access: yes, 2021
HUBUNGAN KECEMASAN DENGAN KETEPATAN KUNJUNGAN ULANG AKSEPTOR KB SUNTIK PROGESTIN PADA MASA PENDEMI COVID-19 DI KLINIK PRATAMA PMI DIY Nofa Rositai1, Heni Puji Wahyuningsih 2, Dwiana Estiwidani3 1,2,3 Jurusan Kebidanan Poltekkes Kemenkes Yogyakarta
Nofa Rosita
core  

Hormone Replacement Therapy Uptake and Discontinuation Trends From 1996‐2023: An Observational Study of the Welsh Population

open access: yesBJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Objective To analyse prescribing trends for oral and transdermal hormone replacement therapy (HRT) in Wales from 1996 to 2023, including predictors of discontinuation within one year of initiation. Design Observational study using the Secure Anonymised Information Linkage (SAIL) databank.
Robin Andrews   +3 more
wiley   +1 more source

What Happens After Menopause (WHAM)? A Progress Report of a Prospective Controlled Study of Women After Pre‐Menopausal Risk‐Reducing Bilateral Salpingo‐Oophorectomy

open access: yesBJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Surgical menopause, the removal of both ovaries prior to natural menopause, may impact short‐and long‐term physical and emotional health. An increasingly common cause of surgical menopause is risk‐reducing salpingo‐oophorectomy (RRSO) in those at high inherited risk of ovarian cancer.
Sarah A. L. Price   +12 more
wiley   +1 more source

Progestin Concentrations Alter Follicle Characteristics and May Affect Quality of Oocytes (Eggs) [PDF]

open access: yes, 2007
Cows were treated with two progestin concentrations to develop ovulatory follicles exposed to different hormone environments. Cows were assigned to Control Group receiving a CIDR for 7 days (4-6 ng/ml of progestin), or to MGA-14 Group receiving 5mg/head ...
Longfellow, Robyn A.   +14 more
core  

Nuclear progestin receptor-like component in human cervical tissue

open access: yes, 1981
To study progestin action in human glandular cervix, we extracted the nuclear pellet with 0.5 M KCl and immediately adsorbed a progestin-binding receptor-like component to hydroxylapatite.
C. A. Pinkert, J. A. Holt, M. A. Lorincz
core   +1 more source

Data from: Nuclear Progestin Receptor Mediated Linkage of Blood Coagulation and Ovulation

open access: yes, 2021
Supplemntal information for a manuscript entitiled "Nuclear Progestin Receptor Mediated Linkage of Blood Coagulation and Ovulation"
Yong Zhu (8726905)   +6 more
core   +1 more source

Advent of NK3R Antagonists for the Treatment of Menopausal Hot Flushes: A Narrative Review

open access: yesBJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT The menopause transition is marked by symptoms predominantly attributed to declining oestrogen levels. Approximately 80% of women experience associated symptoms, and 25% experience severe symptoms. The commonest are vasomotor symptoms (VMS), collectively referring to hot flushes and/or night sweats.
Aaran H. Patel   +5 more
wiley   +1 more source

Women's and Health Care Professionals' Experiences of Discontinuing Hormone Replacement Therapy (HRT): A Systematic Review

open access: yesBJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Background Hormone Replacement Therapy (HRT) is used to manage menopausal symptoms, particularly vasomotor symptoms (VMS). HRT prescribing rates are rising, but most women will eventually discontinue. Objectives To explore the experiences of women stopping HRT, why women restart HRT, and the HCPs advising them. Search Strategy Embase, MEDLINE,
Sarah Bunnewell   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy